Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

Clinical trial NCT00035308 · COMPLETED

Trial details

NCT number: NCT00035308
Sponsor: La Jolla Pharmaceutical Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Immunologic Diseases Autoimmune Diseases Systemic Lupus Erythematosus Lupus Nephritis Lupus Glomerulonephritis

Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.